Source disclosure: January 14, 2026
Daito Pharmaceutical Co., Ltd. [4577.T]
TOKYO, Feb 16 (Pulse News Wire) – Daito Pharmaceutical Co., Ltd. (4577.T) reported consolidated results for Q2 FY2026 (ending May 2026).
1 billion (+2.3% YoY). 63 billion (+10.6%). net profit attributable to shareholders was ¥1.23 billion (+35.8%).
8 billion with an equity ratio of 67.9%. For the next fiscal year, the company forecasts 5 billion (+3.7%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms • Original filing💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.